| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | <![CDATA[Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study]]> | 0 | 15.78 | 05-10-2026 |
| 2 | Time-Dependent Effects of GLP-1 Receptor Agonists on Weight Loss: A Systematic Review and Meta-Analysis of Phase 3 Trials [version 1; peer review: awaiting peer review] | 0 | 13.63 | 08-08-2026 |
| 3 | Длительный прием «Оземпика» возвращает аппетит, не увеличивая потребление калорий | 0 | 7.87 | 24-07-2026 |
| 4 | New GLP-1 pill delivers up to 12% weight loss in 36 weeks | 0 | 11.64 | 10-08-2026 |
| 5 | Semaglutide in pillola, via libera in Europa al primo farmaco orale per la gestione del peso | 0 | 4.94 | 16-07-2026 |
| 6 | Hope for new low cost slimming pill as daily tablet beats oral semaglutide in trial | 0 | 7.86 | 26-02-2026 |
| 7 | Semaglutide Associated With Lower Incidence of OSA in Post Hoc Analysis | 2 | 6 | 26-06-2026 |
| 8 | Number of Americans taking GLP-1s for weight loss hits record high: Survey | 0 | 7 | 07-07-2026 |
| 9 | Борьба с ожирением: как меняется доступность терапии ожирения в России | 0 | 7.59 | 24-09-2026 |